Business Insights, March 2009, Pages: 129
Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based biobanks have been established which
PharmaVentures, July 2007, Pages: 88
opportunity and maximise future success. Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making covers those essential market changing initiatives which make tomorrow’s drug
John Wiley and Sons Ltd, Nov 2008, Pages: 424
to the area, with a historical overview of initial developments of cancer therapeutics and their progress in today’s multidisciplinary approach to cancer treatment. The book not only provides information
Cientifica Ltd., Sep 2011, Pages: 82
market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech’s highest growth sectors.
Targeted drug delivery therapies for the treatment of cancer
Decision Resources, Inc., April 2008, Pages: 40
proteins in clinical development in March 2007: overview of seven therapeutic categories, including blood-related disorders, cardiovascular and central nervous system diseases, cancer, and type 1 and 2
GBI Research, March 2011, Pages: 76
research and in house analysis by a team of industry experts
Fostering Drug Discovery with the Significant Increase in the Number of Biobanks During 1970-2010
Biobanks have recently been developed under the support
NANO Magazine, Dec 2007, Pages: 47
see that the planet is feeling the effects of air and space travel. We spoke to NASA to gain an overview of how nanotechnology will lead to more fuel efficient shuttles and enhance the safety of space
